Biostate AI

Houston, TX · Founded 2023 · Privately Held (backing)

Developer of a biotechnology data aggregation and analysis platform intended for analyzing biopharmaceutical developments. Biostate AI is based in Houston, TX and was founded in 2023. It was valued at $65 million at its early-stage round in May 2025, the last priced event on record. It has raised $16.7 million across 1 recorded round; the latest was a $4.2 million seed round in Apr 2025.

PMV mark · valuation
$65.0M
Oct 2026
Priced at
its early-stage round
May 2025
Total raised
$16.7M
Last round
Seed Round
Apr 2025
What is Biostate AI worth?
$65.0MPrivateMarketView mark · Oct 2026

Valued at $65.0M at its early-stage round, May 2025. Nothing has traded since.

Free account
More of Biostate AI with a free account
  • ·The complete investor list: 23 names
  • ·Watch Biostate AI: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Biostate AI funding history

1 rounds
DateRoundRaisedPost-money
Apr 2025Seed Round$4.2M▮
Unlock post-money valuations

Membership and data by Private Market View

Biostate AI valuation

Biostate AI was valued at $65 million at its early-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Biostate AI raised?

Biostate AI has raised $16.7 million in total; 1 of its rounds is on record. The largest on record was a $4.2 million seed round in Apr 2025.

Biostate AI has filed 1 Form D with the SEC, most recently in May 2025 ($4.2 million sold to 7 investors).

How Biostate AI's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Biostate AI, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Biostate AI

What is Biostate AI worth?
Biostate AI is valued at $65.0M as of Oct 2026. Valued at $65.0M at its early-stage round, May 2025. Nothing has traded since.
How much has Biostate AI raised?
Biostate AI has raised $16.7M in total funding across 1 recorded rounds.
When did Biostate AI last raise?
Biostate AI last raised in Apr 2025 (Seed Round), raising $4.2M.